Position in GH
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,078,692
-$384,364 QoQ
Shares Held
33,330
-1.7% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Pier Capital, LLC holds $9,725,645 across 3 Diagnostics & Research names. GH ranks #2 (31.7% of the industry book) .
All Filings in GH
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,078,692 | 33,330 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,463,056 | 33,905 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $6,636,625 | 106,220 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,767,800 | 72,402 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $5,237,968 | 122,957 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,035,054 | 230,280 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $3,634,361 | 158,429 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $3,345,863 | 115,854 | Shares | Sole | 2024-08-07 | |
| 2020-09-30 | $5,076,600 | 45,416 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,744,068 | 46,149 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,440,828 | 63,805 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||